MCK

#145
McKesson Corporation
864.7200 USD
+0.34%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
863.3700
866.0003
Rango anual
789.9600
999.0000
Cambio diario
+0.34%
Variación mensual
-8.76%
Variación en los últimos 6 meses
+7.75%
Cambio anual
+7.75%
Cierres anteriores
861.7600
Abrir
865.0100
Bid
Ask
Mínimo
863.3700
High
866.0003
Volumen
187
Ver el calendario completo

Financials

Visión general Informes Estadísticas Dividendos
Trimestre Año
  • Market Capitalization 105.9174 B
  • Employee 51 K
  • Founded N/A
  • CEO Brian S. Tyler
  • Website www.mckesson.com
  • Headquarter Delaware, United States
  • FIGI BBG000DYGNW7
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
26.17
Relación precio/flujo de caja
0.24
Dividendos por acción
2.75
Rendimiento por dividendo, %
0.41

McKesson Corporation

McKesson Corporation is an American publicly traded company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a component of the S&P 500 and is listed on the New York Stock Exchange, where it is traded under the ticker symbol "MCK". McKesson provides extensive network of infrastructure for the healthcare industry and was an early adopter of technologies, including barcode scanning for distribution, pharmacy robotics, and RFID tags. The company has been named in a federal lawsuit for profiting from the opioid epidemic in the United States. Throughout the COVID-19 pandemic, McKesson was a key vaccine distributor, serving as the US government's centralized distributor for hundreds of millions of COVID-19 vaccine doses and ancillary supply kits for over a billion doses.

Noticias